PNC Financial Services Group
VYGR icon

PNC Financial Services Group’s Voyager Therapeutics VYGR Stock Holding History

PNC Financial Services Group’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.25K Sell
582
-238
-29% -$937 ﹤0.01% 4544
2025
Q4 		$3.22K Sell
820
-632
-44% -$2.79K ﹤0.01% 4394
2025
Q3 		$6.78K Buy
1,452
+884
+156% +$3.2K ﹤0.01% 4092
2025
Q2 		$1.77K Buy
+568
New +$1.83K ﹤0.01% 4447
2025
Q1 		– Sell
-30
Closed -$170 – 5012
2024
Q4 		$170 Hold
30
– – ﹤0.01% 4662
2024
Q3 		$176 Hold
30
– – ﹤0.01% 4691
2024
Q2 		$237 Buy
+30
New +$251 ﹤0.01% 4641
2023
Q3 		– Sell
-1,100
Closed -$12.6K – 4774
2023
Q2 		$12.6K Buy
+1,100
New +$11.4K ﹤0.01% 3772
2019
Q3 		– Sell
-99,735
Closed -$2.71M – 4120
2019
Q2 		$2.71M Buy
+99,735
New +$2.28M ﹤0.01% 901

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PNC Financial Services Group's VYGR Position: Q1 2026 in Review

PNC Financial Services Group reduced its Voyager Therapeutics (VYGR) stake by 29% in Q1 2026, selling an estimated $937 and leaving 582 shares worth $2.25K. The position accounts for ﹤0.01% of the portfolio, ranked #4544.

PNC Financial Services Group first reported a position in VYGR in Q2 2019 and has held it in 9 quarters since. The position peaked at $2.71M in Q2 2019. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.

  • PNC Financial Services Group held 582 shares of Voyager Therapeutics worth $2.25K as of Q1 2026.
  • PNC Financial Services Group sold 238 Voyager Therapeutics shares in Q1 2026, an estimated $937.
  • Voyager Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #4544 holding.
  • PNC Financial Services Group first reported a position in Voyager Therapeutics in Q2 2019 and has held it in 9 quarters since.
  • PNC Financial Services Group's Voyager Therapeutics position peaked at $2.71M in Q2 2019.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.